SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001214659-23-011668
Filing Date
2023-08-24
Accepted
2023-08-24 16:30:25
Documents
4
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 f821230def14a.htm DEF 14A 154890
2 GRAPHIC alzamendlogo_regmark.jpg GRAPHIC 17222
3 GRAPHIC proxycard1.jpg GRAPHIC 60423
4 GRAPHIC proxycard2.jpg GRAPHIC 65294
  Complete submission text file 0001214659-23-011668.txt   353134
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-40483 | Film No.: 231202554
SIC: 2834 Pharmaceutical Preparations